Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, showcased its product portfolio of high performance rigid and soft-touch plastics for medical devices at the China International Component Manufacturing and Design Show (ICMD) in Shanghai from May 14-17. Trinseo’s booth attracted visitors from Bangladesh, China, India, Korea, Singapore, Taiwan, and as far as the U.S. The exchange of technical information and application ideas have benefited both Trinseo and industrial professionals immensely.
Trinseo medical-grade rigid plastic materials include an array of different high performance resins: MAGNUM™ 8391 MED ABS Resins, STYRON™ 2678 MED PS Resins, CALIBRE™ PC Resins with unique attributes that cross markets, and CALIBRE™ MEGARAD™ PC Resins being an advanced material for devices requiring gamma or electron-beam irradiation. The Company’s soft plastics consist of the MEGOL™ family of TPS-SEBS compounds that offers the ideal combination of the elasticity, appearance, and haptics of rubber together with the low processing costs of thermoplastics; while RAPLAN™ TPS materials are an ideal substitute for PVC when halogen-free products are required.
Amy Wang, Trinseo’s Senior Technical Service and Development Engineer conducted a presentation Medical Plastic One-Stop Solution – Engineering Plastics and Elastomer from Trinseo at the technical forum at ICMD on May 15. Her presentation attracted an attendance of more than 200 people. Some of the attendees came to the Trinseo booth after the presentation to explore more on how the Company’s soft plastics help solve their material challenges.
To learn more about Trinseo’s innovation, experience, and expertise in medical device resins, please click here.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.